Clinical Trials Directory

Trials / Sponsors / Genovate Biotechnology Co., Ltd.,

Genovate Biotechnology Co., Ltd.,

Industry · 13 registered clinical trials.

StatusTrialPhaseStarted
CompletedBE Study of Once Daily PMR Compared to Twice Daily Cilostazol Tablets in Healthy Volunteers
Intermittent Claudication
Phase 12023-11-28
CompletedBE Study of Once Daily PMR Compared to Twice Daily Cilostazol IR Tablets in Healthy Volunteers
Intermittent Claudication
Phase 12022-07-05
TerminatedBioequivalence Study of PMR Compared to Cilostazol IR Tablets in Healthy Volunteers
Intermittent Claudication
Phase 12022-04-23
CompletedBioequivalence Study of Once Daily PMR Compared to Twice Daily Cilostazol IR Tablets in Healthy Volunteers
Intermittent Claudication
Phase 12019-02-11
CompletedPharmacokinetic Study of Once Daily PMR Compared to Twice Daily Cilostazol IR Tablets in Healthy Volunteers
Intermittent Claudication
Phase 12018-03-06
TerminatedAssess the Safety and Effectiveness of Once Daily PMR Compared to Twice Daily Pletaal® in Patients With Interm
Intermittent Claudication
Phase 32016-03-14
CompletedMycophenolate Mofetil Versus Azathioprine for Maintenance Therapy of Lupus Nephritis
Lupus Nephritis
Phase 22015-07-01
UnknownMycophenolate Sodium (Myfortic®) in the Treatment of Corticosteroid-refractory Autoimmune Uveitis:Pilot Study
Uveitis
—2009-01-01
UnknownImproving Cognitive Function of Aripiprazole in Treating Adolescents and Young Adults With Psychotic Disorder
Psychotic Disorders
—2007-11-01
UnknownReversal of Antipsychotic-Induced Hyperprolactinemia, Weight Gain, Hyperglycemia and Dyslipidemia
Hyperprolactinemia, Weight Gain, Dyslipidemia
Phase 42007-10-01
CompletedType 2 Diabetes Patients Switched From Sulfonylurea With Metformin to Glyburide/Metformin Combination Tablet
Type 2 Diabetes Mellitus
—2006-05-01
UnknownCombigan Ophthalmic Solution(Brimonidine 0.2% and Timolol 0.5%)With Latanoprost Compared With Latanoprost Mono
Glaucoma
Phase 42006-05-01
CompletedEfficacy and Safety Study of Nidadd in the Management of Hyperlipidemia
Hyperlipidemia
Phase 32003-10-01